Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations
Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft
Cancer Res Treat. 2024;56(3):847-855. Published online 2024 Feb 7 DOI: https://doi.org/10.4143/crt.2023.1197
Citations to this article as recorded by 
Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib
Ludovica Gnagni, Ilary Ruscito, Ilaria Grazia Zizzari, Marianna Nuti, Chiara Napoletano, Aurelia Rughetti
Critical Reviews in Oncology/Hematology.2024; 202: 104464. CrossRef